RecruitingPhase 4NCT03855046

Complex Treatment of a Chronic Anal Fissure

Studying Chronic graft versus host disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
State Scientific Centre of Coloproctology, Russian Federation
Principal Investigator
Sergey A. Frolov, Ph.D.
State Scientific Centre of Coloproctology, Russian Federation (SSCCRussia)
Intervention
IncobotulinumtoxinA 50 U Intramuscular Powder for Solution(drug)
Enrollment
340 target
Eligibility
18-70 years · All sexes
Timeline
2019 – 2022

Study locations (7)

Collaborators

St. Petersburg State Pavlov Medical University · Astrakhan State Medical University · Siberian State Medical University · City Clinical Hospital №24, Department of Health City of Moscow · GBUZ MO "Lvovskaia Raionaia Bolnica" · Medical Center ON-CLINIC

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03855046 on ClinicalTrials.gov

Other trials for Chronic graft versus host disease

Additional recruiting or active studies for the same condition.

See all trials for Chronic graft versus host disease →

← Back to all trials